TMEM184 Antibodies

Santa Cruz Biotechnology features a diverse variety of TMEM184 monoclonal antibodies for investigating TMEM184 protein function. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TMEM184 is a transmembrane protein involved in membrane trafficking and signal transduction pathways. Research has shown TMEM184's significance in various physiological and pathological conditions, particularly in cancer and neurodegenerative diseases. TMEM184 continues to emerge as a promising therapeutic target through ongoing scientific investigations. Researchers can utilize specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection flexibility. Advanced research techniques enable detailed examination of TMEM184 localization, expression patterns, and molecular interactions. Santa Cruz Biotechnology monoclonal antibodies for TMEM184 support researchers worldwide in advancing scientific understanding of cellular processes and disease mechanisms.